Intranasal administration of resolvin E1 attenuates lipopolysaccharide-induced depression-like behaviors via BDNF/VEGF release and mTORC1 activation in the medial prefrontal cortex
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.